"Die Klinik für Gastroenterologie und Hepatologie am Universitätsspital Zürich bietet umfassende Diagnostik und Therapie bei Krankheitsbildern der Gastroenterologie und Hepatologie an. Neben bester Diagnostik und modernster Therapie legen wir besonderen Wert auf Vorsorge und Früherkennung sowie eine umfassende Nachbetreuung nach Eingriffen."

During the past decade, Division of Gastroenterology, University Hospital Zurich conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Division of Gastroenterology, University Hospital Zurich" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "Schweizerischer Nationalfonds" with 1 trials as a collaborator, "Swiss Federal Institute of Technology in Zurich (ETHZ)" with 1 trials as a collaborator and "University of Bern" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Division of Gastroenterology, University Hospital Zurich" are "Healthy" (4 trials), "Ulcerative Colitis" (3 trials), "Crohn Disease" (2 trials), "Flare Up, Symptom" (2 trials) and "Healthy Participants" (2 trials). Many other conditions were trialed in "Division of Gastroenterology, University Hospital Zurich" in a lesser frequency.

Most popular intervention types in "Division of Gastroenterology, University Hospital Zurich" are "Other" (6 trials), "Drug" (5 trials), "Behavioral" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Exposure to golimumab" (2 trials), "Lipid emulsion" (2 trials), "Placebo" (2 trials), "Blood samples" (1 trials) and "Clinical information" (1 trials). Other intervention names were less common.

The vast majority of trials in "Division of Gastroenterology, University Hospital Zurich" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Division of Gastroenterology, University Hospital Zurich". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Division of Gastroenterology, University Hospital Zurich, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Division of Gastroenterology, University Hospital Zurich, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".